- Home
- FATE vs SVII Comparison
FATE vs SVII Comparison
Compare FATE & SVII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- SVII
- Stock Information
- Founded
- FATE 2007
- SVII 2021
- Country
- FATE United States
- SVII United States
- Employees
- FATE N/A
- SVII N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- SVII Blank Checks
- Sector
- FATE Health Care
- SVII Finance
- Exchange
- FATE Nasdaq
- SVII Nasdaq
- Market Cap
- FATE 108.2M
- SVII 113.1M
- IPO Year
- FATE 2013
- SVII 2022
- Fundamental
- Price
- FATE $1.28
- SVII $11.60
- Analyst Decision
- FATE Hold
- SVII
- Analyst Count
- FATE 8
- SVII 0
- Target Price
- FATE $5.43
- SVII N/A
- AVG Volume (30 Days)
- FATE 2.5M
- SVII 8.5K
- Earning Date
- FATE 05-08-2025
- SVII 01-01-0001
- Dividend Yield
- FATE N/A
- SVII N/A
- EPS Growth
- FATE N/A
- SVII N/A
- EPS
- FATE N/A
- SVII 0.33
- Revenue
- FATE $13,631,000.00
- SVII N/A
- Revenue This Year
- FATE N/A
- SVII N/A
- Revenue Next Year
- FATE N/A
- SVII N/A
- P/E Ratio
- FATE N/A
- SVII $35.59
- Revenue Growth
- FATE N/A
- SVII N/A
- 52 Week Low
- FATE $0.66
- SVII $11.02
- 52 Week High
- FATE $5.92
- SVII $11.70
- Technical
- Relative Strength Index (RSI)
- FATE 60.93
- SVII 69.63
- Support Level
- FATE $1.02
- SVII $11.48
- Resistance Level
- FATE $1.49
- SVII $11.55
- Average True Range (ATR)
- FATE 0.17
- SVII 0.01
- MACD
- FATE 0.05
- SVII 0.00
- Stochastic Oscillator
- FATE 74.07
- SVII 100.00
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About SVII Spring Valley Acquisition Corp. II
Spring Valley Acquisition Corp II is a blank check company.